Background High Risk Foot Clinic (HRFC) patients have foot ulceration commonly associated with poorer quality of life (QoL). A positive SARC-F test is predictive of sarcopenia. The objective of this study is to investigate whether SARC-F positive status is associated with lower QoL among attendees of HRFC, which is currently unknown.
Introduction
Lower limb neuropathy and vascular disease are commonly associated with diabetes and lead to a high risk of foot ulceration which can lead to amputation. Outpatient clinics that specifically look after patients with dysvascular foot disease are effective in reducing these patients' complications and hospitalisations [1] , [2] . These clinics are usually called 'Diabetic Foot Clinics' or 'High Risk Foot Clinics' depending on whether diabetes is a criterion for patient inclusion. Hospital admissions with diabetic foot disease have been estimated to cost over a billion dollars in Australia alone [3] . Dysvascular foot disease is associated with disability and reduced quality of life on a number of validated tools for measuring quality of life such as SF-36 and NeuroQol [4] , [5] . The SARC-F questionnaire was originally developed as a screening test for sarcopenia [6] . The SARC-F questionnaire comprises five questionnaire items that assess the respondents' strength, assistance required in walking, ability to rise from a chair, ability to climb stairs, and history of falls. It is a quick questionnaire which is easy to administer in the outpatient setting. A SARC-F questionnaire score of four or more predicts the presence of sarcopenia. This instrument has been demonstrated to accurately identify patients with poorer physical performance, both in individuals who have sarcopenia [7] and in the general population [8] , [9] . SARC-F is also predictive for poor prognosis in patients with sarcopenia and in the general population in terms of physical performance, hospitalization and mortality [7] .
While it is known that both SARC-F positive status and dysvascular foot disease is associated with reduced quality of life [4] , [5] , the association between the positive SARC-F status with a further reduction in quality of life in the High Risk Foot Clinic population is unknown. This study aims to investigate whether being SARC-F positive, as measured by a positive SARC-F score of 4 or above, is associated with a further reduction in quality of life in patients with dysvascular foot disease. We also conducted exploratory analyses of the correlation between individual components and domains of SARC-F and EQ-5D-3L instruments in this patient population.
Methods

Study population
This cross-sectional study with prospectively collected data was performed in patients attending a multidisciplinary High Risk Foot Clinic at a metropolitan tertiary referral hospital in Melbourne, Victoria, Australia. This clinic manages patients who have foot disease secondary to vascular or neurological disease. Patients are accepted for review regardless of their diabetes status.
All new patients who presented to the clinic between February 2017 to February 2018 were eligible to participate in the study. Inclusion criteria were for the patient to be cognitively intact, over the age of 18 years, and willing to complete the questionnaires. Patients were excluded if they were cognitively impaired, under the age of 18, and could not communicate with staff due to non English speaking status and lack of interpreter availability. The study was approved by St Vincent's Hospital Melbourne Ethics Committee (QA 003/17), who waived the requirement for informed consent. The study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Data collection
General demographic information and comorbidities via Charlson Comorbidity Index were collected. Patients were asked to complete the SARC-F questionnaire and the EQ-5D-3L questionnaire. Charlson Comorbidity Index is an instrument that measures the patients' burden of disease by describing comorbidies (such as diabetes, malignancy and liver disease) and age. This index was originally developed to predict one year mortality [10] , but is more commonly used to describe the extent of an individual's illness and disability.
The SARC-F questionnaire is a 5 item instrument that was developed and validated as a screening tool for sarcopenia [6] , [7] (On Line Appendix Fig 1) . This questionnaire was more recently demonstrated to accurately identify patients with poorer physical performance and those at risk of adverse outcomes from sarcopenia [7] , [8] . It consists of 5 questions regarding the participant's strength, mobility, ability to rise from a chair, climbing stairs, and falls. Possible scores range from 0 to 10, with higher score indicating worse function.
The EQ-5D-3L questionnaire (EuroQol Group 1990) is a 6 item instrument that was developed and validated to assess participants' perception of their quality of life. It consists of 5 questions regarding mobility, personal care, usual activities, pain/discomfort and anxiety/depression, as well as a health 'thermometer' that estimates the participant's overall health state using a visual analogue scale from 0 to 10, with higher score indicating better quality of life. Possible scores for the questionnaire range from 0 to 10, with a higher score indicating worse quality of life in the relevant domain.
Power analysis
Power analysis for this study was conducted in the absence of relevant pilot data and was primarily based on feasibility considerations. It was projected that it would be feasible for the clinic in question to recruit up to 100 patients over a calendar year. This sample size provides a precision (half width of the 95% Confidence Interval) of 0.1 to estimate the prevalence of being SARC-F positive of 0.5, while any other prevalence can be estimated with higher precision. This sample size will also provide 0.8 power to identify at least a medium strength association between SARC-F and VAS score (Rho=0.3), assuming two sided Alpha level of 0.05.
Statistical analysis
Continuous variables were summarized as medians and interquartile ranges (IQRs), and categorical variables were summarized as counts and proportions. The differences in sociodemographic and clinical characteristics between patients excluded from and included in the study, as well as SARC-F positive and SARC-F negative patients were investigated using MannWhitney or Fisher's exact test as appropriate.
The association between SARC-F status and EQ-5D-3L visual analogue scale thermometer outcomes was investigated using a linear regression model with robust standard errors either unadjusted or adjusted for patients' gender and Charlson comorbidity score. These adjustment covariates were prospectively selected due to the known association with quality of life [11] , [12] . Corresponding effect sizes were reported as mean difference with 95% confidence intervals. The association between SARC-F status and individual dimensions of EQ-5D-3L was investigated using ordinal logistic regression model either unadjusted or adjusted for patients' gender and Charlson comorbidity score. Proportional odds assumptions were examined using the Brant test. Corresponding effect sizes were reported as common Odds Ratios (cOR) with 95% confidence intervals. Common Odds Ratios above/below 1 are interpreted as increase/decrease in cumulative odds of achieving worse outcome on individual EQ-5D-3L dimensions.
Pair wise correlations between individual components of SARC-F score and individual dimensions of EQ-5D-3L were estimated using Spearman's correlation coefficient. Corresponding p values reported in the results were corrected for multiplicity of comparisons using Bonferroni correction procedure.
Statistical analysis was conducted using Stata v14IC statistical software (StataCorp, College Station, TX, USA). Two-sided p values of 0.05 were considered as indicative of statistical significance.
Results
Study population
Over the 12 months study period, 122 new patients attended the HRFC. The EQ-5D-3L and SARC-F questionnaires were completed by 84 new patients (69%) that were subsequently included in the study. No significant differences between included and excluded patients in age (p=0.34), gender (p >0.999), diabetes status (p=0.72), Charcot's arthropathy status (p>0.999) or Charlson comorbidity score (p=0.056) were identified, not indicative of the presence of selection bias.
The characteristics of included patients were: median age 69 (IQR 59-80, min 28, max 92), male gender 63 (75%), 75 patients (88%) had diabetes. The median age adjusted Charlson comorbidity score was 8 (IQR 6-11), while 13 patients (15%) had unilateral or bilateral Charcot arthropathy.
Out of patients who completed the questionnaires, 43 (51%; 95%CI: 40%, 62%) were SARC-F positive (score of 4 or more). Table 1 describes the characteristics of SARC-F positive and SARC-F negative patients. SARC-F positive patients were more likely to be female (15 (35%) vs 7 SARC-F negative female patients (15%), Fisher's exact p=0.044). No significant difference was identified between SARC-F positive and negative patients in terms of age, diabetes status, Charlson score, or presence of Charcot arthropathy. The distribution of SARC-F scores is described in On Line Appendix Table 1 . 
Quality of life measures
The mean EQ-5D-3L health state thermometer reading among the HRFC attendees was 5.9 (SD 2.0), and the median was 6.0 (IQR 5.0-7.0). SARC-F positive patients had a statistically significantly lower EQ-5D-3L health state thermometer reading (mean 5.3 (SD 2.0); median 5.0 (IQR: 4.0, 6.5)), indicating a worse quality of life, compared to SARC-F negative patients ((mean 6.6 (SD 1.9); median 7.0 (IQR 5.5, 7.5), unadjusted mean difference: -1.3 (95% CI -2.2, -0.5; p=0.003); mean difference adjusted for gender and Charlson comorbidity score: -1.2 (95%CI: -2.1, -0.4; p=0.007)) (Figure 1 Panel A). SARC-F positive patients demonstrated consistent and statistically significantly higher EQ-5D-3L scores on mobility, personal care and usual activities, indicating worse performance in these domains, but not on anxiety and depression and pain and discomfort (Table 2, Figure 1 Panels B-F). (Table 3 b) Correlation between individual components of EQ-5D-3L Significant correlations were identified between the following components of EQ-5D-3L questionnaire: Mobility and Usual activities items (p<0.001), and Personal care and Usual activities items (p<0.001).
Exploratory analysis of the association between individual components of SARC-F and EQ-5D-3L
c) Correlations between individual components of SARC-F and EQ-5D-3L As demonstrated in Table 3 , the Mobility, Personal care and Usual activities components of EQ-5D-3L positively and significantly correlated with SARC-F components of Strength, Assistance in walking, Rise from a chair, and Climb stairs, but not with Falls. The Pain or discomfort and Anxiety or depression components of EQ-5D-3L did not positively correlate with any components of SARC-F.
Discussion
The present study found that patients with dysvascular disease who attend High Risk Foot Clinic and who are SARC-F positive also have a lower quality of life than those who are SARC-F negative, as assessed on both the visual analogue scale health thermometer and on the mobility, usual activities, and personal care components. There was also a positive correlation between SARC-F and EQ-5D-3L components that assess mobility and performance of daily tasks.
The findings in the current study may be explained through the combination of the important role of physical and functional domains in the overall quality of life, and the prominent presence of the mobility and daily task performance components in the SARC-F tool, constituting 3 out of its 5 domains. A potential implication of the findings of the present study is that administering the SARC-F tool may have an important and role in investigating patients' health related quality of life.
The assessment of health related quality of life is highly patient-centric and is increasingly used to assess burden of disease and impact of treatment in a variety of medical conditions [13] , [14] . All commonly used multidimensional quality of life measures, such as these administered by EuroQol group (such as EQ-5D and EQ-3D, ref), AQoL instruments (such as AQoL 8D [15] ) and Optum SF Health Surveys (such as SF-36, ref) include components that assess mobility and daily task performance.
Sarcopenia is a disorder of muscle mass and function [16] , which is associated with poorer functional performance, greater disability, institutionalization and death [17] . Sarcopenic patients are known to be prevalent in High Risk Foot Clinics [18] and SARC-F tool is a validated screening method for sarcopenia [6] , [7] . Patients with sarcopenia are known to have a poorer quality of life in the community [19] . This study presents the first empirical demonstration that the SARC-F positive patients in the High Risk Foot Clinic population have a poorer quality of life than the SARC-F negative ones which is generally consistent with findings in sarcopenic patients in other populations.
The main approaches to treatment of sarcopenia are progressive resistance exercise and optimization of dietary protein intake [20] , [21] . As treating sarcopenia is likely to improve patients' SARC-F score, it can be hypothesized that allied health intervention that specifically aims to maximize patients' mobility and independence in performing daily tasks may improve quality of life. In view of tight financial constrains that are typical for ambulatory hospital services, SARC-F may be used as an important triage tool that assists in determining which patients should be referred for prioritized allied health intervention. This study has limitations. It was conducted in one clinic of a single metropolitan tertiary referral hospital, which may affect the generalizability of results. At the same time, this clinic's case mix is typical for HRFCs Australia wide. Further, within the settings of this specific clinic, the issue of selection bias has been addressed and no bias on any of the patient characteristics perceived to be important for this study was identified.
Conclusions/Relevance
Approximately half of the patients who attend the High Risk Foot Clinic are SARC-F positive. These patients exhibit lower quality of life as measured by EQ-5D-3L compared to SARC-F negative patients. The SARC-F questionnaire may have a role in investigating patients' quality of life, as well as in triaging patients for allied health intervention. Further study is needed to address the changes in the quality of life of the SARC-F positive population after allied health intervention aiming to specifically optimize the patients' mobility and self care performance and their nutritional status. Table A1 . Individual components of SARC-F
